SUPN
SUPERNUS PHARMACEUTICALS, INC.
SUPERNUS PHARMACEUTICALS, INC. (SUPN) has 4 SEC Form 4 filings (26 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Mar 18, 2026.
The most active filer is Sr. VP of IP, CSO Bhatt Padmanabh P. with 3 filings. Insiders have net sold $8.2M over the trailing 6 months.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Jack A. Khattar
- Employees:674
- HQ:Rockville, MD, US
- IPO:2012-05-01
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$9.7M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
Bhatt Padmanabh P.First filing | Sr. VP of IP, CSO | Sale | 50,000 | $2.5M | Mar 18 | SEC ↗ |
Bhatt Padmanabh P.First filing | Sr. VP of IP, CSO | Sale | 50,000 | $2.5M | Mar 18 | SEC ↗ |
Bhatt Padmanabh P.First filing | Sr. VP of IP, CSO | Sale | 7,250 | $360K | Mar 18 | SEC ↗ |
Khattar Jack A.First in 7 months | President, CEO | Sale | 35,000 | $1.8M | Mar 16 | SEC ↗ |
GEMAYEL GEORGESFirst filing | Director | Sale | 10,000 | $537K | Mar 9 | SEC ↗ |
GEMAYEL GEORGESFirst filing | Director | Sale | 8,787 | $466K | Mar 9 | SEC ↗ |
Khattar Jack A.First filing | President, CEO | Sale | 10,650 | $480K | Aug 29 | SEC ↗ |
Khattar Jack A.First filing | President, CEO | Sale | 24,150 | $1.1M | Aug 29 | SEC ↗ |
Related companies
SUPERNUS PHARMACEUTICALS, INC. is in the Healthcare sector.